In contrast, A20 overexpression within stromal CD3+ T cells in the peripheral tumor area was significantly associated with ameliorated OS of tumor patients in the multivariable survival analysis (0.582; 95% CI 0.388–0.873, p = 0.009). The gene discussed is TNFAIP3; the disease is neoplasm.